Search

Your search keyword '"Weiss, Nora"' showing total 28 results
Start Over Author "Weiss, Nora" Publisher springer science and business media llc
28 results on '"Weiss, Nora"'

2. Evaluation of an impedance-based method to monitor the insertion of the electrode array during cochlear implantation

Author

Gottfried, Timo M., primary, Galeazzi, Pablo, additional, Föger, Aline, additional, Dejaco, Daniel, additional, Tröger, Andrea, additional, Fischer, Natalie, additional, Innerhofer, Veronika, additional, Di Trapani, Francesco, additional, Weiss, Nora, additional, Seebacher, Josef, additional, Dierker, Angelika, additional, and Schmutzhard, Joachim, additional

Published
2024
Full Text
View/download PDF

11. CT imaging-based approaches to cochlear duct length estimation—a human temporal bone study

Author

Breitsprecher, Tabita, primary, Dhanasingh, Anandhan, additional, Schulze, Marko, additional, Kipp, Markus, additional, Dakah, Rami Abu, additional, Oberhoffner, Tobias, additional, Dau, Michael, additional, Frerich, Bernhard, additional, Weber, Marc-André, additional, Langner, Soenke, additional, Mlynski, Robert, additional, and Weiss, Nora M., additional

Published
2021
Full Text
View/download PDF

20. Evaluating the didactic value of 3D visualization in otosurgery

Author

Weiss, Nora M., primary, Schneider, Armin, additional, Hempel, John M., additional, Uecker, Florian C., additional, van Bonn, Sara M., additional, Schraven, Sebastian P., additional, Rettschlag, Stefanie, additional, Schuldt, Tobias, additional, Müller, Joachim, additional, Plontke, Stefan K., additional, and Mlynski, Robert, additional

Published
2020
Full Text
View/download PDF

27. Characteristics of health-related quality of life in different types of chronic middle ear disease

Author

Wilma Großmann, Nora M Weiss, David Bächinger, Robert Mlynski, University of Zurich, and Weiss, Nora M

Subjects
Adult, Male, medicine.medical_specialty, Hearing loss, Ear, Middle, 610 Medicine & health, 10045 Clinic for Otorhinolaryngology, Mastoid, 03 medical and health sciences, Tympanoplasty, 0302 clinical medicine, Quality of life, Internal medicine, Vertigo, otorhinolaryngologic diseases, medicine, Humans, Longitudinal Studies, Prospective Studies, 030223 otorhinolaryngology, Retrospective Studies, Cholesteatoma, Middle Ear, medicine.diagnostic_test, biology, business.industry, Cholesteatoma, General Medicine, medicine.disease, biology.organism_classification, humanities, Otitis Media, Treatment Outcome, 2733 Otorhinolaryngology, medicine.anatomical_structure, Otorhinolaryngology, 030220 oncology & carcinogenesis, Chronic Disease, Quality of Life, Middle ear, Female, Neurosurgery, medicine.symptom, Audiometry, business
Abstract

Different types of chronic middle ear disease (CMED) present with differing severity of single symptoms, such as discharge, vertigo or hearing loss, which impair health-related quality of life (HRQoL). Here, we aimed to (i) investigate characteristics of HRQoL and (ii) evaluate the association between HRQoL and hearing among different types of CMED. In this prospective longitudinal cohort study, we included adult patients undergoing surgical treatment for CMED. Primary outcomes included HRQoL assessed by the Zurich Chronic Middle Ear Inventory (ZCMEI-21) and hearing assessed by pure-tone audiometry. In the included 108 patients (51% females), CMED were chronic otitis media (COM) with (n = 46) or without (n = 22) cholesteatoma, persistent mastoid cavity (with [n = 15] or without [n = 10] recurrent cholesteatoma), revision ossiculoplasty for hearing restoration (n = 14), and postinflammatory meatal fibrosis (n = 1). Preoperatively, the mean ZCMEI-21 score showed statistically significant differences among different types of CMED (p = 0.007) with persistent mastoid cavity without cholesteatoma exhibiting the highest score (34.1, SD 7.7) indicating poor HRQoL. At a mean follow-up period of 183 days, no statistically significant differences in the ZCMEI-21 scores among different types of CMED were observed (p = 0.67). This study objectifies differences in HRQoL among different types of CMED. In patients with indication for functional surgery only, e.g., persistent mastoid cavity without cholesteatoma, the worst HRQoL was observed. Yet, in these types of CMED, HRQoL guides decision for treatment. Moreover, differences in HRQoL among different types of CMED were not closely associated with hearing, but largely depended on other symptoms, such as discharge or vertigo.

Published
2020

28. Mastoid cavity obliteration leads to a clinically significant improvement in health-related quality of life

Author

Robert Mlynski, David Bächinger, Jannik Botzen, Nora M Weiss, Wilma Großmann, University of Zurich, and Weiss, Nora M

Subjects
Male, medicine.medical_specialty, Chronic middle ear disease, Mastoidectomy, medicine.medical_treatment, Otology, 610 Medicine & health, 10045 Clinic for Otorhinolaryngology, Mastoid, Tympanoplasty, Bone conduction, Quality of life, medicine, Humans, Prospective Studies, Chronic otitis media, Cholesteatoma, Obliteration, Mastoid cavity, Retrospective Studies, ZCMEI-21, Cholesteatoma, Middle Ear, business.industry, General Medicine, Middle Aged, medicine.disease, Surgery, Treatment Outcome, 2733 Otorhinolaryngology, medicine.anatomical_structure, Otorhinolaryngology, Quality of Life, Middle ear, Female, Neurosurgery, business
Abstract

Objective To assess the change in health-related quality of life (HRQoL) in patients undergoing mastoid cavity obliteration. Methods Patients who had undergone canal wall-down mastoidectomy for chronic otitis media with creation of a persistent mastoid cavity and underwent revision tympanomastoid surgery including mastoid cavity obliteration using autologous material were included. Audiological measurements including air conduction (AC) and bone conduction (BC) pure-tone averages (PTA) and the air–bone gap (ABG) were assessed. Health-related Quality of Life (HRQoL) was assessed by the Zurich Chronic Middle Ear Inventory (ZCMEI-21) pre- and postoperatively. Results A total of 25 patients (16 females and 9 males; mean age 51.6 years, 14 right and 11 left ears) were included. Patients were reexamined after a mean follow-up period of 9.2 months (SD = 6.5) after obliteration of the mastoid cavity. Compared to the preoperative visit, patients showed a significantly reduced AC PTA at the postoperative visit (mean difference: − 4.1; SD = 10.4, p = 0.045). The mean ZCMEI-21 score changed from 31.7 (SD = 14.5) preoperatively to 17.4 (SD = 15.1) postoperatively (mean difference: − 14.3; SD = 19.1; p = 0.0002). The mean ZCMEI-21 score changes were neither correlated to the AC PTA shift (p = 0.60) nor to the ABG shift (p = 0.66). Conclusions This is the first study reporting a highly significant and clinically important improvement in HRQoL after mastoid cavity obliteration in a prospective setting. The improvement in HRQoL was not correlated to the hearing improvement. As a clinical implication, we provide evidence for a substantial subjective benefit of the surgical obliteration of a symptomatic mastoid cavity and, therefore, encourage this surgical procedure.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results